News
Retail chatter around Klotho Neurosciences picked up late Thursday after the company said that the FDA had granted Orphan Drug Designation to its ALS gene therapy candidate, KLTO-202. The designation ...
11h
TipRanks on MSNKlotho Neurosciences Receives FDA Orphan Drug DesignationKlotho Neurosciences ( ($KLTO) ) has provided an announcement. On July 10, 2025, Klotho Neurosciences announced that the FDA granted Orphan Drug ...
Klotho shares have soared more than 1000% over the past three months on promising results and breakthrough hopes.
Investing.com -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) stock surged 22% after the company announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its ...
US Stocks Likely To Open Lower A Day After Nasdaq Hits Record High: Nvidia, Kellogg, Klotho In Focus
U.S. stock futures declined on Thursday after ending higher on Wednesday. Futures of major benchmark indices were trading ...
Boosting Klotho protein levels in mice improves physical and cognitive aging, offering potential for future longevity ...
Klotho is advancing its ALS gene therapy candidate KLTO‑202 to the manufacturing phase, and is planning the first human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results